Stock PYFA PT PYRIDAM FARMA TBK
Add to a list
To use this feature you must be a member
Log inSign up

Company PT Pyridam Farma Tbk

Equities

PYFA

ID1000075609

Pharmaceuticals

End-of-day quote INDONESIA S.E.
Other stock markets
 06:00:00 2024-06-04 pm EDT 		5-day change 1st Jan Change
113 IDR -4.24% Intraday chart for PT Pyridam Farma Tbk -14.39% -90.13%
May. 10 Foreign Investment Review Board Clears Probiotec Acquisition by Pyridam Farma MT
Mar. 15 PT Pyridam Farma Tbk Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

PT Pyridam Farma Tbk is an Indonesia-based pharmaceutical company. The Company is engaged in the production, development, and trade of pharmaceuticals, as well as the trade of medical devices and cosmetics. Its segments include pharmaceutical products, esthetic, and toll manufacturing services; and medical equipments. It offers products across consumer health, pyfaesthetic, sanitizer and antiseptic, sterile/injection, biomedilab, betadine group and guardix, and medical support categories. The consumer health category provides over the counter drugs, including supplements and other preventive products, along with energy drinks and healthy ready-to-drink products. Its pyfaesthetic category includes products, such as Arosa Gel, A-Stark Gel, Hymen Gel, Pyderen Emulsion, Tonic Bust Emulsion, Calmosan Cream, and Di-Herb Gel. Its sterile/injection category is focused on injection products. Its biomedilab category provides various medical equipment and tools for hospital laboratories.

Number of employees: 1,193

Sales per Business

IDR in Million2022Weight2023Weight Delta
Pharmaceutical Products, Esthetic and Toll Products and Toll Manufacturing Services
98.4 %
666,109 93.1 % 690,970 98.4 % +3.73%
Medical Equipment
1.6 %
49,316 6.9 % 11,098 1.6 % -77.50%

Sales per region

IDR in Million2022Weight2023Weight Delta
Indonesia
100.0 %
715,425 100.0 % 702,068 100.0 % -1.87%

Managers

Managers TitleAgeSince
Yan Gwan Lee CEO
 Chief Executive Officer 61 20-08-13
Yenfrino Gunadi DFI
 Director of Finance/CFO 38 20-08-13
Bedjo Stefanus PRN
 Corporate Officer/Principal 60 23-06-21
Yoshiana AUD
 Comptroller/Controller/Auditor 30 21-11-18
Nadia Miranty Verdiana SEC
 Corporate Secretary 33 20-10-31
Paulus Widjanarko Brotosaputro SAM
 Sales & Marketing 59 19-05-20
Helena PRN
 Corporate Officer/Principal - -
Budiharja Halim HRO
 Human Resources Officer - -

Members of the board

Members of the board TitleAgeSince
Mohammad Syamsul Arifin BRD
 Director/Board Member 71 15-05-24
Robby Yulianto CHM
 Chairman 42 20-08-13
Maura Linda Sitanggang BRD
 Director/Board Member 65 22-03-09
Charles D. Marpaung BRD
 Director/Board Member 69 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 535,080,000 193,069,188 ( 36.08 %) 0 36.08 %

Holdings

NameEquities%Valuation
PROBIOTEC LIMITED
10.33%
 8,400,873 10.33% 15,656,119 $

Company contact information

PT Pyridam Farma Tbk

Sinarmas MSIG Tower Jl. Jend. Sudirman No. Kav. 21

11530, Jakarta

+

http://www.pyfa.co.id
address PT Pyridam Farma Tbk(PYFA)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
PT PYRIDAM FARMA TBK Stock PT Pyridam Farma Tbk
-90.13% 77.91M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+42.69% 749B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+38.79% 605B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.87% 351B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.74% 328B
ABBVIE INC. Stock AbbVie Inc.
+6.76% 292B
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.85% 248B
ROCHE HOLDING AG Stock Roche Holding AG
-2.33% 214B
NOVARTIS AG Stock Novartis AG
+11.31% 216B
PFIZER, INC. Stock Pfizer, Inc.
+2.64% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. PYFA Stock
  4. Company PT Pyridam Farma Tbk